Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA American Academy of Clinical Toxicology Ad Hoc Committee on the Treatment Guidelines for Methanol Poisoning. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002; 40:415–446. [PubMed] [Google Scholar]

R obledo C, Saracho R. Methanol poisoning caused by inhalation of solvent. Nefrología (English Edition). 2018 Nov 1;38(6):679-80.

Sanaei-Zadeh H, Zamani N, Shadnia S. Outcomes of visual disturbances after methanol poisoning. Clinical Toxicology. 2011 Feb 1;49(2):102-7.

Rui Zhang, Xuebin Wang, Leng Ni, Xiao Di, Baitao Ma, Shuai Niu, Changwei Liu, Russel J. Reiter,COVID-19: Melatonin as a potential adjuvant treatment,Life Sciences,Volume 250,2020,117583,

Jacobsen D, McMartin KE. Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol. 1986; 1:309–334. [PubMed] [Google Scholar]

Hovda KE, Hunderi OH, Rudberg N, Froyshov S, Jacobsen D. Anion and osmolal gaps in the diagnosis of methanol poisoning: clinical study in 28 patients. Intensive care medicine. 2004 Sep;30(9):1842-6.

Hovda KE, Hunderi OH, TAFJORD AB, Dunlop O, Rudberg N, Jacobsen D. Methanol outbreak in Norway 2002–2004: epidemiology, clinical features and prognostic signs. Journal of internal medicine. 2005 Aug;258(2):181-90.

Sefidbakht S, Rasekhi AR, Kamali K, Haghighi AB, Salooti A, Meshksar A, Abbasi HR, Moghadami M, Nabavizadeh SA. Methanol poisoning: acute MR and CT findings in nine patients. Neuroradiology. 2007 May 1;49(5):427-35.

Yousefinejad V, Moradi B, Baneh AM, Sheikhesmaeili F, Babahajian A. Prognostic factors of outcome in methanol poisoning; an 8-year retrospective cross-sectional study. Archives of academic emergency medicine. 2020;8(1).

Paasma R, Hovda KE, Jacobsen D. Methanol poisoning and long term sequelae–a six years follow-up after a large methanol outbreak. BMC clinical pharmacology. 2009 Dec;9(1):1-5.

Galvez-Ruiz A, Elkhamary SM, Asghar N, Bosley TM. Visual and neurologic sequelae of methanol poisoning in Saudi Arabia. Saudi medical journal. 2015 May;36(5):568.

Hassanian-Moghaddam H, Pajoumand A, Dadgar SM, Shadnia SH. Prognostic factors in methanol poisoning. Human & experimental toxicology. 2007 Jul;26(7):583-6.

Sanaei-Zadeh H, Zamani N, Shadnia S. Outcomes of visual disturbances after methanol poisoning. Clin Toxicol (Phila) 2011; 49:102–107. [PubMed] [Google Scholar]

Brent J, McMartin K, Phillips S, Aaron C, Kulig K Methylpyrazole for Toxic Alcohols Study Group. Fomepizole for the treatment of methanol poisoning. N Engl J Med. 2001; 344:424–429. [PubMed] [Google Scholar]

Shukla M, Shikoh I, Saleem A. Intravenous methylprednisolone could salvage vision in methyl alcohol poisoning. Indian journal of ophthalmology. 2006 Jan 1;54(1):68-9.

Abrishami M, Khalifeh M, Shoayb M, Abrishami M. Therapeutic effects of high-dose intravenous prednisolone in methanol-induced toxic optic neuropathy. Journal of ocular pharmacology and therapeutics. 2011 Jun 1;27(3):261-3.

Ma Z, Jiang H, Wang J. Clinical analysis of severe visual loss caused by inhalational methanol poisoning in a chronic process with acute onset: a retrospective clinical analysis. BMC ophthalmology. 2019 Dec;19(1):1-7.

Sharma P, Sharma R. Toxic optic neuropathy. Indian journal of ophthalmology. 2011 Mar;59(2):137.

Korkmaz A, Reiter RJ, Topal T, Manchester LC, Oter S, Tan DX. Melatonin: an established antioxidant worthy of use in clinical trials. Molecular medicine. 2009 Jan;15(1):43-50.

Mostafalou S, Abdollahi M. Pesticides: an update of human exposure and toxicity. Archives of toxicology. 2017 Feb;91(2):549-99.

Romero A, Ramos E, de Los Ríos C, Egea J, Del Pino J, Reiter RJ. A review of metal‐catalyzed molecular damage: protection by Melatonin. Journal of Pineal Research. 2014 May;56(4):343-70.

Asghari MH, Moloudizargari M, Bahadar H, Abdollahi M. A review of the protective effect of Melatonin in pesticide-induced toxicity. Expert Opinion on Drug Metabolism & Toxicology. 2017 May 4;13(5):545-54.

Aranda ML, Fleitas MFG, Dieguez H, Iaquinandi A, Sande PH, Dorfman D, et al. Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases. Curr Neuropharmacol. 2017;15(7):1–2.

Aranda ML, González Fleitas MF, De Laurentiis A, Keller Sarmiento MI, Chianelli M, Sande PH, et al. Neuroprotective effect of Melatonin in experimental optic neuritis in rats. J Pineal Res. 2016;60(3):360–72.

Carrascal L, Nunez-Abades P, Ayala A, Cano M. Role of Melatonin in the Inflammatory Process and its Therapeutic Potential. Curr Pharm Des. 2018;24(14):1563–88.

del Valle Bessone C, Fajreldines HD, de Barboza GED, Tolosa de Talamoni NG, Allemandi DA, Carpentieri AR, et al. Protective role of Melatonin on retinal ganglionar cell: In vitro an in vivo evidences. Life Sci. 2019;218(Cdc):233–40.

J Wei , L-S Ma, D-J Liu, J Guo, W-K Jiang, H-J Yu. Melatonin regulates traumatic optic neuropathy via targeting autophagy. Eur Rev Med Pharmacol Sci. 2017 Nov;21(21):4946-4951

Juybari KB, Hosseinzadeh A, Ghaznavi H, Kamali M, Sedaghat A, Mehrzadi S, et al. Melatonin As a Modulator of Degenerative and Regenerative Signaling Pathways in Injured Retinal Ganglion Cells. Curr Pharm Des. 2019;25(28):3057–73.

Qiao Sun, Mingming Sun, Yuan Zhang, Song Wang, Wenhao Bai, Shihui Wei, Quangang Xu, Huanfen Zhou, "Clinical Characteristics of Methanol-Induced Optic Neuropathy: Correlation between Aetiology and Clinical Findings", Journal of Ophthalmology, vol. 2022, Article ID 4671671, 11 pages, 2022. https://doi.org/10.1155/2022/4671671

L.P.H. Andersen, I. Gogenur, J. Rosenberg, R.J. Reiter

The safety of Melatonin in humans Clin. Drug Investig., 36 (2016), pp. 169-175, 10.1007/s40261 015-0368-5

G. Mistraletti, M. Umbrello, G. Sabbatini, S. Miori, M. Taverna, B. Cerri, E.S. Mantovani, P. Formenti, P. Spanu, A. D’Agostino, S. Salini, A. Morabito, F. Fraschini, R.J. Reiter, G. Iapichino, Melatonin reduces the need for sedation in ICU patients: a randomized controlled trial Minerva Anestesiol., 81 (2015), pp. 1298-1310

G. Mistraletti, G. Sabbatini, M. Taverna, M.A. Figini, M. Umbrello, P. Magni, M. Ruscica, E. Dozio, R. Esposti, G. DeMartini, F. Fraschini, R. Rezzani, R.J. Reiter, G. Iapichino

Pharmacokinetics of orally administered Melatonin in critically ill patients

J. Pineal Res., 48 (2010), pp. 142-147, 10.1111/j.1600-079X.2009.00737.x

J.J. Nordlund, A.B. Lerner

The effects of oral Melatonin on skin color and on the release of pituitary hormones

J. Clin. Endocrinol. Metab., 45 (1977), pp. 768-774, 10.1210/jcem-45-4-768